CD47 and ovarian carcinoma: The relevance of targeting the TSP-1: CD47 axis in ovarian cancer was confirmed, enabling simultaneous targeting of different components of the ovarian microenvironment with a single molecule (Fig. 2 in Supplementary material) [23].